This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Thyroid Neoplasms, Thyroid Cancer or Thyroid Nodule
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

Thyroid cancer affects 6,000 Canadians each year. Nodules on the thyroid are detected using ultrasound imaging and surgery is the most common treatment. However, most nodules are benign, and therefore a biopsy is needed to decide whether surgery is necessary. Ultrasound imaging is very sensitive for localizing nodules, but does not differentiate between cancerous and benign ones. To address this limitation of US imaging, investigators have designed and constructed, in collaboration with Sogang University, Seoul, S. Korea, a novel imaging system that performs complimentary imaging modalities (ultrasound (US), photoacoustic (PA)) that could potentially help diagnose nodules without the need for biopsy and unnecessary surgery.

Provided treatments

  • Device: Tri-modal imaging
Tris trial is registered with FDA with number: NCT02758158. The sponsor of the trial is University Health Network, Toronto and it is looking for 9 volunteers for the current phase.
Official trial title:
Clinical Evaluation of a Prototype Tri-modal Imaging Instrument for Thyroid Cancer